All News
STAT+: Novartis to pay $1 billion upfront to license Huntington’s drug from PTC
Novartis is paying $1 billion upfront in a licensing deal for an experimental Huntington’s disease treatment from PTC Therapeutics.
Read MoreBeatriz v El Salvador: the abortion case that could set a precedent across Latin America
Activists targeted as US-linked hard-right campaigns sow disinformation ahead of inter-American court of human rights ruling on case of woman who was denied abortion in 2013Earlier this year, Morena H
Read MoreDAIS hosts Cadaver Workshop 2024 in Miami
The event aimed to provide a learning experience and a collaborative space where surgeons could interact with technology developers, exchange ideas, and give feedback The post DAIS hosts Cadaver Work
Read MoreWhat does the tightness of our clothes say about our emotions? You’d be surprised
Desperate to be swaddled, embraced or comforted? You may find yourself reaching for a skintight T-shirt or some Kim Kardashian shapewearNow that winter has arrived, with its bone-chilling winds and da
Read MoreHealth Ministry provides update on health insurance for senior citizens
Approximately 14 lakh Ayushman Vay Vandana cards have been created, for senior citizens aged 70 years and above The post Health Ministry provides update on health insurance for senior citizens appear
Read MoreWho Gets Obesity Drugs Covered by Insurance? In North Carolina, It Helps If You’re on Medicaid
GLP-1 agonist medications such as Ozempic accounted for 10% of the North Carolina state employee health plan’s prescription drug spending, so the state is no longer covering them for weight loss alo
Read MoreNHS bosses reportedly worried about Starmer’s pledge to cut waiting lists
PM expected to set target to carry out 92% of routine operations and appointments within 18 weeksUK politics live – latest updatesNHS bosses are said to be privately concerned about Keir Starmer’s
Read MoreScientists confront a mystery: Why have U.S. bird flu cases been so mild?
The H5N1 bird flu outbreak in the U.S. has so far been shockingly mild. Researchers have some theories as to why.
Read MoreSTAT+: ‘Significant talent shortage’ threatens the rise of radiopharmaceuticals
There's growing interest in radiopharmaceuticals. But a "significant talent shortage" may threaten the field's rise.
Read MoreOpinion: Congress’ critical opportunity to reshape health care
The lame-duck Congress can end the year on a rare bipartisan health care high note by passing two bills.
Read More